(Q46167132)

20 December 2017

title

Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats (English)

1 reference

20 December 2017

0 references

5

Jaime Bosch

1 reference

20 December 2017

author name string

Marc Mejias

1

1 reference

20 December 2017

Ester Garcia-Pras

2

1 reference

20 December 2017

Carolina Tiani

3

1 reference

20 December 2017

Rosa Miquel

4

1 reference

20 December 2017

Mercedes Fernandez

6

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

20 December 2017

published in

Hepatology

1 reference

20 December 2017

volume

49

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

1245-1256

1 reference

20 December 2017

How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers.

cites work

1 reference

Blood vessel formation: what is its molecular basis?

21 January 2018

1 reference

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

21 January 2018

1 reference

Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.

21 January 2018

1 reference

NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.

21 January 2018

1 reference

The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats

21 January 2018

1 reference

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

21 January 2018

1 reference

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.

21 January 2018

1 reference

Portal hypertension after bile duct obstruction: effect of bile diversion on portal pressure in the rat.

21 January 2018

1 reference

21 January 2018

1 reference

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough

21 January 2018

1 reference

Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells

21 January 2018

1 reference

Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?

21 January 2018

1 reference

Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms

21 January 2018

1 reference

Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.

21 January 2018

1 reference

Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity

21 January 2018

1 reference

Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites

21 January 2018

1 reference

Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function

21 January 2018

1 reference

Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats

21 January 2018

1 reference

Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma

21 January 2018

1 reference

Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis

21 January 2018

1 reference

Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.

21 January 2018

1 reference

Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review

21 January 2018

1 reference

Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats

21 January 2018

1 reference

7 January 2021

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats

1 reference

7 January 2021

Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation

1 reference

7 January 2021

Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats

1 reference

7 January 2021

Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis

1 reference

7 January 2021

Gene expression profiling in whole liver of bile duct ligated rats: VEGF-A expression is up-regulated in hepatocytes adjacent to the portal tracts

1 reference

7 January 2021

Bacterial translocation in acute and chronic portal hypertension

1 reference

7 January 2021

Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22758

1 reference

20 December 2017

PubMed ID

19137587

1 reference

20 December 2017